Rising Costs of Oral Anticancer Drugs Burden Medicare Recipients; New Law May Provide Some Relief
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
All articles by Alan P. Lyss, MD
Sublobar Resection Should Be New Standard Care for Certain Patients With NSCLC
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
How to Improve Outcomes for Older Patients With Ovarian Cancer
An expert outlines ways to improve outcomes for older patients with ovarian cancer.
Medicaid Expansion May Have Improved Access to Cancer Trials
The expansion of Medicaid eligibility was associated with a nearly 3-fold increase in the proportion of Medicaid-covered patients enrolled in cancer treatment trials.
High-Deductible Health Plans Linked to Delayed Diagnosis of Metastatic Cancer
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
Eponyms in Oncology: Peutz-Jeghers Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Peutz-Jeghers syndrome.
Eponyms in Oncology: Von Hippel-Lindau Disease
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of von Hippel-Lindau disease.
Eponyms in Oncology: Bence-Jones Protein
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Bence-Jones protein.
Long-Term Benefit Observed With Sotorasib in KRAS-Mutant Non-Small Cell Lung Cancer
The 2-year overall survival rate was 32.5%.
Eponyms in Oncology: Zollinger-Ellison Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Zollinger-Ellison syndrome.
- Loading...
Loading...
Next post in Eponyms in Oncology
Loading... 
Loading...